Table 2: Relationship between prognostic parameters and IMP3 expression.
Prognostic parameters |
IMP3 expression |
Conclusion |
||||
Negative |
1+ |
2+ |
3+ |
|||
Age group |
≤ 45 (n = 26) |
6 (23.1%) |
15 (57.7%) |
4 (15.4%) |
1 (3.8%) |
p = 0.097 |
> 45 (n = 34) |
6 (17.6%) |
11 (32.4%) |
12 (35.3%) |
5 (14.7%) |
||
Gender |
Female (n = 46) |
6 (13.1%) |
22 (47.8%) |
14 (30.4%) |
4 (8.7%) |
p = 0.070 |
Male (n = 14) |
6 (42.9%) |
4 (28.6%) |
2 (14.3%) |
2(14.3%) |
||
Tumor size |
1.1-4 cm (n = 34) |
5 (14.7%) |
15 (44.1%) |
9 (26.5%) |
5 (14.7%) |
p = 0.322 |
> 4 cm (n = 11) |
3 (27.3%) |
4 (36.4%) |
3 (27.3%) |
1 (9.1%) |
||
Histological subtype |
Papillary carcinoma (n = 50) |
9 (18.0%) |
21 (42.0%) |
14 (28.0%) |
6 (12.0%) |
p = 0.830* |
Medullary carcinoma (n = 5) |
2 (40.0%) |
3 (60.0%) |
0 (0.0%) |
0 (0.0%) |
||
Anaplastic carcinoma (n = 1) |
0 (0.0%) |
0 (0.0%) |
1 (100%) |
0 (0.0%) |
||
WDTUMP (n = 4) |
1 (25.0%) |
2 (50.0%) |
1 (25.0%) |
0 (0.0%) |